Sio Gene Therapies Inc

:AXGT   3:59:58 PM EDT
2.65
+0.18 (+7.29%)
Products

Axovant Gene Therapies Announces FDA Clearance Of IND For AXO-AAV-GM2 Gene Therapy In Tay-Sachs And Sandhoff Diseases

Published: 11/09/2020 12:17 GMT
(AXGT) - Axovant Gene Therapies Announces FDA Clearance of Ind for Axo-aav-gm2 Gene Therapy in Tay-sachs and Sandhoff Diseases.
Axovant Gene Therapies - Received Letter From FDA Indicating That Co Has Satisfactorily Addressed All Issues Related to Clinical Hold on Axo-aav-gm2.